Garlic Oil Suppressed Nitrosodiethylamine-Induced Hepatocarcinoma in Rats by Inhibiting PI3K-AKT-NF-κB Pathway

Cui-Li Zhang1, Tao Zeng1, Xiu-Lan Zhao1

  • 1Institute of Toxicology, School of Public Health, Shandong University, 44 Wenhua West Road, Jinan 250012, Shandong, P.R. China.

Insights

Garlic oil (GO) protects against liver cancer induced by nitrosodiethylamine (NDEA) in rats. GO suppresses key cancer markers and the PI3K-AKT-NF-κB signaling pathway, offering a potential therapeutic strategy.

Area of Science:

  • Hepatocellular Carcinoma Research
  • Natural Product Chemistry
  • Molecular Biology

Background:

  • Hepatocellular carcinoma (HCC) poses a significant global health challenge.
  • Nitrosodiethylamine (NDEA) is a known carcinogen used to induce HCC in experimental models.
  • Investigating natural compounds for chemopreventive properties is crucial for developing novel therapies.

Purpose of the Study:

  • To elucidate the protective mechanisms of garlic oil (GO) against NDEA-induced hepatocarcinoma in a rat model.
  • To assess the impact of GO on key biomarkers of liver cancer progression.
  • To explore the molecular pathways modulated by GO in hepatocarcinogenesis.

Main Methods:

  • Rats were divided into control, NDEA-induced, and GO + NDEA groups.
  • GO was administered at 20 or 40 mg/kg before and during NDEA exposure for 20 weeks.
  • Serum alpha fetal protein (AFP), histological analysis (H&E, Sirius Red), PCNA expression, and Western blotting for PI3K/AKT/NF-κB pathway proteins were performed.

Main Results:

  • GO co-treatment significantly reduced NDEA-induced increases in serum AFP, nuclear atypia, and Sirius Red-positive areas.
  • GO suppressed proliferating cell nuclear antigen (PCNA) expression, indicating reduced cell proliferation.
  • GO reversed NDEA-induced upregulation of PI3K, AKT phosphorylation, IκB degradation, and NF-κB activation.

Conclusions:

  • Garlic oil demonstrates significant protective effects against NDEA-induced hepatocarcinoma in rats.
  • GO's chemopreventive action is linked to the suppression of the PI3K-AKT-NF-κB signaling pathway.
  • These findings suggest GO as a potential therapeutic agent for preventing or treating liver cancer.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.7K